Table of Contents
Volume 5 | Supplement 1
Publication Date: September 2003- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Introduction | ||
S4 |
Novel Targeted Therapies: A Challenge for Drug Development Chandra P. Belani |
|
Contributions | ||
S5-S10 |
The Impact of Gefitinib on Epidermal Growth Factor Receptor Signaling Pathways in Cancer Steven D. Averbuch |
|
S11-S17 |
Biologically Targeted Treatment of Non–Small-Cell Lung Cancer: Focus on Epidermal Growth Factor Receptor Ronald B. Natale |
|
S18-S21 |
Pharmacokinetic Evaluation of Gefitinib When Administered with Chemotherapy Lisa A. Hammond |
|
S22-S28 |
Molecular Targeted Agents in Non–Small-Cell Lung Cancer Alan B. Sandler |
|
S29-S35 |
Adjuvant Systemic Therapies in Early-Stage Non–Small-Cell Lung Cancer Joan H. Schiller |
|
S36-S40 |
Primary and Secondary Prevention of Non–Small-Cell Lung Cancer: The SPORE Trials of Lung Cancer Prevention* Fadlo Raja Khuri |
|